# Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)

> **NCT02623998** · PHASE3 · COMPLETED · sponsor: **Population Health Research Institute** · enrollment: 102 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** insulin glargine
- **DRUG:** sitagliptin/metformin
- **BEHAVIORAL:** lifestyle therapy

## Key facts

- **NCT ID:** NCT02623998
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-09
- **Primary completion:** 2018-09-01
- **Final completion:** 2019-11-30
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2022-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02623998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02623998, "Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02623998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*